Glaxosmithkline Pharmaceuticals Ltd Q3 FY2024-2025 Results: Summary

Revenue
₹984.49Cr
Net Profits
₹229.88Cr
Net Profit Margins
23.35%
Highlights
Revenue:

Glaxosmithkline Pharmaceuticals Ltd’s revenue jumped 18.13% since last year same period to ₹984.49Cr in the Q3 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -6.24% fall in its revenue since last 3-months.

Net Profits:

Glaxosmithkline Pharmaceuticals Ltd’s net profit jumped 402.8% since last year same period to ₹229.88Cr in the Q3 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -8.96% fall in its net profits since last 3-months.

Net Profit Margins:

Glaxosmithkline Pharmaceuticals Ltd’s net profit margin jumped 325.62% since last year same period to 23.35% in the Q3 2024-2025. On a quarterly growth basis, Glaxosmithkline Pharmaceuticals Ltd has generated -2.9% fall in its net profit margins since last 3-months.

FAQs

What was the revenue for Glaxosmithkline Pharmaceuticals Ltd in Q3 results 2024?

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2024 was ₹984.49Cr.

What was the net profit for Glaxosmithkline Pharmaceuticals Ltd in Q3 results 2024?

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2024 was ₹229.88Cr.

What was the net profit margin for Glaxosmithkline Pharmaceuticals Ltd in Q3 results 2024?

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2024 was 23.35%.

What was the revenue for Glaxosmithkline Pharmaceuticals Ltd in Q3 results 2023?

The revenue for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2023 was ₹833.37Cr.

What was the net profit for Glaxosmithkline Pharmaceuticals Ltd in Q3 results 2023?

The net profit for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2023 was ₹45.72Cr.

What was the net profit margin for Glaxosmithkline Pharmaceuticals Ltd in Q3 results 2023?

The net profit margin for Glaxosmithkline Pharmaceuticals Ltd in the Q3 results 2023 was 5.49%.